The Neuropathology and Genetics (NPG) Core will perform laboratory analyses on biological fluids collected from living subjects and brain tissue collected at autopsy of participants in the Mayo Alzheimer Disease Research Center (ADRC). The data will be communicated to the Clinical Core using standardized protocols and procedures. The NPG Core will also provide neuropathologic diagnoses and support to research projects related to Alzheimer's disease at the Mayo Clinic.
The specific aims are: 1.) Perform brain autopsies on participants of the ADRC. 2.) Provide neuropathologic evaluations and collect neuropathologic data using standardized neuropathologic methods for gross dissections and neurohistology. 3.) Photograph, map and measure vascular lesions and reach consensus about the clinical significance of vascular lesion to cognitive impairment with regular videoconferences and quarterly clinicopathological conferences in Rochester. 4.) Perform immunostaining with antibodies to alpha-synuclein on all cases with either neuronal loss in the substantia nigra or Lewy bodies. 5.) Characterize non- Alzheimer dementia cases with immunocytochemistry and electron microscopy and provide DNA and tissue samples on these cases to Dr. Mike Hutton who is studying biochemistry and genetics of non-Alzheimer dementias. 6.) Provide fixed and frozen brain samples to Project 1 (PI: Dr. S.-H. Yen). 7.) Quantify postmortem white matter pathology with image analysis for correlative studies in Project 3 (PI: Dr. C.R. Jack). 8.) Perform ELISA assays for A-beta of postmortem brain tissue to estimate amyloid burden for correlative studies. 9.) Provide clinically and pathologically well-characterized tissue samples for research on other projects of Mayo investigators. 10.) Bank blood and CSF and perform apolipoprotein-E genotyping on all subjects in the ADRC. Provide plasma samples to Dr. S.G.Younkin for A-beta assays that are integral to his other research projects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG016574-01S4
Application #
6396651
Study Section
Project Start
1999-09-30
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A et al. (2018) Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment. Clin Neuropsychol 32:524-529
Jones, David T; Knopman, David S; Graff-Radford, Jonathan et al. (2018) In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms. Neurology 90:e947-e954
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Wennberg, Alexandra M V; Lesnick, Timothy G; Schwarz, Christopher G et al. (2018) Longitudinal Association Between Brain Amyloid-Beta and Gait in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci 73:1244-1250
Wennberg, Alexandra M V; Hagen, Clinton E; Edwards, Kelly et al. (2018) Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging. Int J Geriatr Psychiatry 33:1114-1120
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Sahoo, Aradhana; Bejanin, Alexandre; Murray, Melissa E et al. (2018) TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia. J Alzheimers Dis 64:1227-1233

Showing the most recent 10 out of 1014 publications